Management of gastro-esophageal reflux disease in primary care. Results from an observational study of 2,474 patients (AO)

Gastroenterol Clin Biol. 2007 Jan;31(1):72-7. doi: 10.1016/s0399-8320(07)89329-8.

Abstract

Objective: The aim of the present study was to describe the management of gastro-esophageal reflux disease (GERD) by primary care physicians (PCPs).

Methods: This prospective survey was conducted in patients with suspected or previously diagnosed GERD. PCPs completed questionnaires at first consultation (M0) and at a 3-month follow-up visit (M3).

Results: 2 474 patients were available for analysis at M0 and 1 993 at M3. GERD was the reason for consultation in 84% of patients; 33% were consulting about reflux symptoms for the first time. Symptoms occurred once daily in 55% of patients and were considered very disruptive or incapacitating by 51%. Upper gastrointestinal endoscopy was performed at any time in 57% of patients and at M0 in 20%. Only 48% of demands for endoscopy agreed with current recommendations and this rate was not influenced by PCP training in the previous 6 months. Lifestyle measures were recommended in 95% of patients at M0. Proton pump inhibitors were prescribed in 98%, to be taken "on-demand" in 22-57% depending on symptom frequency. Therapeutic management was considered as very satisfactory by 81% of patients.

Conclusions: GERD managed in primary care is severe, leading to expensive, but effective diagnostic investigations and treatments. Agreement with recommendations for endoscopy is poor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Endoscopy, Gastrointestinal*
  • Female
  • France
  • Gastroesophageal Reflux / diagnosis*
  • Gastroesophageal Reflux / therapy*
  • Gastrointestinal Agents / therapeutic use*
  • Guideline Adherence / statistics & numerical data
  • Humans
  • Life Style
  • Male
  • Middle Aged
  • Patient Satisfaction
  • Practice Guidelines as Topic
  • Primary Health Care* / statistics & numerical data
  • Prospective Studies
  • Proton Pump Inhibitors*
  • Surveys and Questionnaires
  • Treatment Outcome

Substances

  • Gastrointestinal Agents
  • Proton Pump Inhibitors